Certolizumab pegol Completed Phase 2 / 3 Trials for Rheumatoid Arthritis Treatment

IndicationsStatusPurposePhase
CompletedTreatment2 / 3
clinicaltrials.gov IdentifierTitleDrugs
NCT02293590RICE: Remission by Intra-articular Injection Plus CErtolizumab
NCT02430909Multiple Dose Study of UCB4940 as add-on to Certolizumab Pegol in Subjects With Rheumatoid Arthritis